Can tamoxifen and a pde5 inhibitor slow the progression of peyronie's disease?
Megson, Matthew, Merrett, Christopher, Ilg, Marus, Cellek, Prof. Selim, Ralph, Prof. David
Published in Journal of sexual medicine (01.11.2022)
Published in Journal of sexual medicine (01.11.2022)
Get full text
Journal Article
(118) THE MECHANISM OF ACTION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS IN PREVENTING MYOFIBROBLAST TRANSFORMATION IN IN VITRO MODELS OF PEYRONIE’S DISEASE
Sophie L, Harding, Dr. Marcus M, Ilg, Dr. Alice R, Lapthorn, Prof. Selim, Cellek, Prof. David J, Ralph
Published in Journal of sexual medicine (06.07.2023)
Published in Journal of sexual medicine (06.07.2023)
Get full text
Journal Article
Investigating the role of extracellular vesicles in peyronie's disease
Ilg, Marcus, Dyer, Dr. Paul, Bustin, Prof. Stephen, Ralph, Prof. David, Cellek, Prof. Selim
Published in Journal of sexual medicine (01.11.2022)
Published in Journal of sexual medicine (01.11.2022)
Get full text
Journal Article
Defining a temporal gene expression profile of myofibroblast transformation in peyronie's disease
Ilg, Marcus, Harding, Sophie, Lapthorn, Dr. Alice, Kirvell, Dr. Sara, Schurman, Nathan, Church, Sarah, Ralph, Prof. David, Bustin, Prof. Stephen, Cellek, Prof. Selim
Published in Journal of sexual medicine (01.11.2022)
Published in Journal of sexual medicine (01.11.2022)
Get full text
Journal Article